The Business Research Company’s report on the Malaria Treatment Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the malaria treatment market?
The high incidence of malaria is expected to propel the growth of the malaria treatment market going forward. Malaria refers to a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite, characterized by recurring fever and other flu-like symptoms. This shift has resulted from poverty, limited access to healthcare IT & Communication Technology, climate change, lack of malaria control measures, and drug resistance. Malaria treatment helps to effectively manage and cure the infection caused by the Plasmodium parasite. For instance, according to the World malaria report 2023 by World Health Organization, a Switzerland-based intergovernmental organization, global malaria cases reached 249 million in 2022, an increase of five million compared to 2021. Therefore, the high incidence of malaria is driving the growth of the malaria treatment market.
Access Your Free Sample of the Global Malaria Treatment Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp
How has the malaria treatment market size evolved, and what are the latest forecasts for its expansion?
The malaria treatment market size has grown steadily in recent years. It will grow from $1.55 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to the discovery of effective drugs, vector control efforts, global health initiatives, scientific research, and health infrastructure development
The malaria treatment market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to drug resistance monitoring, climate change impact, precision medicine and genomic approaches, healthcare financing reforms, and integration of digital health solutions. Major trends in the forecast period include epidemiological surveillance enhancement, alternative medicine integration, malaria vaccine development, data-driven treatment programs, and education and training programs.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=11939&type=smp
Which major companies dominate the malaria treatment market?
Major companies operating in the malaria treatment market include Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontières, Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited
What trends will shape the future of the mail order pharmacy market?
Major companies operating in the malaria treatment market are developing technologies such as the VERV Program to enhance the efficiency and effectiveness of malaria diagnostics and treatments, ultimately aiming to reduce the burden of the disease in endemic regions. The VERV Program is an EPA initiative that encourages the development of new mosquito control products to fight diseases like malaria by offering expedited review vouchers for registration. For instance, in December 2023, the Environmental Protection Agency (EPA), a US-based government agency, launched the Vector Expedited Review Voucher (VERV) Program. The VERV Program will provide financial incentives to companies that develop new pesticides specifically targeting mosquito populations resistant to traditional insecticides. The program will facilitate faster registration processes for qualifying products, thereby expediting their availability in the market.
Which region dominates the malaria treatment market, and what factors contribute to its leadership?
Middle East and Africa was the largest region in the malaria treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report
How is the malaria treatment market segmented, and which segment holds the largest share?
The malaria treatment market covered in this report is segmented –
1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments
2) By Route Of Administration: Oral, Parenteral, Intravenous
3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications
2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines
3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests
4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11939
How is the malaria treatment market defined?
Malaria treatment refers to the medical interventions and procedures used to diagnose, manage, and cure malaria, which is a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
